Bismuth Subcitrate Potassium

bismuth subcitrate potassium · H2-Pharma, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bismuth Subcitrate Potassium, covering 2013-08-14 to 2025-03-31. Get the full timeline:

Most recent: FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)